| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.4735L |
| P356 | DOI | 10.1073/PNAS.0510019103 |
| P932 | PMC publication ID | 1450239 |
| P698 | PubMed publication ID | 16537417 |
| P5875 | ResearchGate publication ID | 7241964 |
| P50 | author | Jens Tank | Q33308739 |
| Michael Bader | Q37611575 | ||
| Elena Popova | Q57006294 | ||
| P2093 | author name string | Rainer Dietz | |
| Nidal Al-Saadi | |||
| Ines Pagel-Langenickel | |||
| Jens Buttgereit | |||
| Thomas H Langenickel | |||
| Ralph Plehm | |||
| Knut Beuerlein | |||
| Maren Lindner | |||
| Roland Willenbrock | |||
| Jan Monti | |||
| P2860 | cites work | Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide | Q28208582 |
| A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse | Q28235995 | ||
| The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system | Q28506517 | ||
| Regulation of the Guanylyl Cyclase-B Receptor by Alternative Splicing | Q28508538 | ||
| Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant | Q67899433 | ||
| Isolation of glomeruli from mammalian kidneys by graded sieving | Q70425908 | ||
| Action of C-type natriuretic peptide in isolated canine arteries and veins | Q70555577 | ||
| Modulation of the beta-adrenergic response of cardiomyocytes by specific lipoxygenase products involves their incorporation into phosphatidylinositol and activation of protein kinase C | Q72809009 | ||
| C-type natriuretic peptide: a selective cardiovascular peptide | Q72955879 | ||
| Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells | Q73709653 | ||
| Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans | Q74292383 | ||
| Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A | Q28511919 | ||
| Forced homodimerization by site-directed mutagenesis alters guanylyl cyclase activity of natriuretic peptide receptor B | Q28569975 | ||
| Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts | Q28575103 | ||
| Dendroaspis natriuretic peptide induces the apoptosis of cardiac muscle cells | Q33213493 | ||
| Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells | Q34263871 | ||
| A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy | Q34486162 | ||
| Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice | Q34998675 | ||
| Cardiac fibrosis in mice lacking brain natriuretic peptide | Q35677878 | ||
| Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs | Q37693870 | ||
| Dominant negative mutations of the guanylyl cyclase-A receptor. Extracellular domain deletion and catalytic domain point mutations | Q38299888 | ||
| Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system" | Q40512524 | ||
| Agonistic induction of a covalent dimer in a mutant of natriuretic peptide receptor-A documents a juxtamembrane interaction that accompanies receptor activation | Q40836202 | ||
| Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide | Q41273237 | ||
| Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. | Q42450367 | ||
| Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide | Q42454978 | ||
| Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts | Q42460581 | ||
| Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload | Q42475794 | ||
| Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching | Q42511344 | ||
| Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice | Q43939730 | ||
| Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. | Q44301908 | ||
| Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice | Q44512015 | ||
| Rat corin gene: molecular cloning and reduced expression in experimental heart failure | Q44904436 | ||
| Autonomic nervous system and blood pressure regulation in RGS2-deficient mice | Q45232056 | ||
| Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats | Q48129178 | ||
| Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds | Q48788742 | ||
| Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy | Q48848544 | ||
| Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. | Q51530571 | ||
| Cardiovascular and renal actions of C-type natriuretic peptide | Q54277308 | ||
| Efficiency of transgenic rat production is independent of transgene-construct and overnight embryo culture | Q56963560 | ||
| Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism | Q57790997 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4735-4740 | |
| P577 | publication date | 2006-03-14 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. | |
| P478 | volume | 103 |
| Q24657949 | A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation |
| Q40082312 | Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP. |
| Q34127995 | Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors |
| Q51564269 | Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. |
| Q39007435 | B-type natriuretic peptide and heart failure: what can we learn from clinical trials? |
| Q30909922 | BNP and Heart Failure: Preclinical and Clinical Trial Data. |
| Q91891449 | C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature |
| Q36708991 | C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target |
| Q92565210 | C-type natriuretic peptide co-ordinates cardiac structure and function |
| Q36895049 | C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells |
| Q33777629 | Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes |
| Q52926690 | Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. |
| Q92528676 | Cardiovascular Pleiotropic Effects of Natriuretic Peptides |
| Q30382842 | Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome. |
| Q36119104 | Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling |
| Q37420916 | Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics |
| Q24655560 | Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux |
| Q36954799 | Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. |
| Q37429352 | Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development |
| Q37336602 | Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation |
| Q92641654 | Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction |
| Q33792340 | Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte |
| Q50587653 | Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families. |
| Q35057768 | Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure |
| Q38028652 | In vivo models of cardiac diseases: application to drug development and screening |
| Q92302079 | Modeling heart failure in animal models for novel drug discovery and development |
| Q38794203 | Molecular Physiology of Membrane Guanylyl Cyclase Receptors |
| Q37914058 | Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. |
| Q51038470 | Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice. |
| Q37766468 | NPR-C: a component of the natriuretic peptide family with implications in human diseases. |
| Q26778333 | Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events |
| Q28297738 | Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy |
| Q54483068 | Natriuretic peptide receptors and heart failure: to B or not to B blocked? |
| Q37863198 | Natriuretic peptide system: an overview of studies using genetically engineered animal models |
| Q38211333 | Natriuretic peptides in cardiometabolic regulation and disease |
| Q34906050 | Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications |
| Q46866129 | Normal brain development in importin-alpha5 deficient-mice |
| Q40455345 | Novel bifunctional natriuretic peptides as potential therapeutics. |
| Q34301501 | Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux. |
| Q51760265 | Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. |
| Q26765883 | Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? |
| Q52955865 | Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice. |
| Q52642700 | Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death. |
| Q34597060 | Regulation of hippocampal synaptic plasticity thresholds and changes in exploratory and learning behavior in dominant negative NPR-B mutant rats. |
| Q64989905 | Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons. |
| Q48783244 | Responses of the trout cardiac natriuretic peptide system to manipulation of salt and water balance |
| Q36773152 | Rodent models of heart failure |
| Q90622067 | Star-PAP controlled alternative polyadenylation coupled poly(A) tail length regulates protein expression in hypertrophic heart |
| Q30539041 | Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I |
| Q37591961 | Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases |
| Q24598242 | miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy |
Search more.